These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6180520)

  • 21. A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17.
    McMichael AJ; Parham P; Rust N; Brodsky F
    Hum Immunol; 1980 Sep; 1(2):121-9. PubMed ID: 6167544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cytotoxic anti-HLA-AB monoclonal antibody which in dilution becomes specific to HLA-A3 crossreacting group.
    Mazzilli MC; Cascino I; Porrini SC; Lavaggi MV; Lulli P; Morellini M; Testa L; Gandini E
    Tissue Antigens; 1984 Aug; 24(2):107-12. PubMed ID: 6208633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of common determinants of HLA antigens A2 and B17 by absorption using human HLA serum].
    Májský A; Korínková P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):768-72. PubMed ID: 6198261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA serological cross-reactivity: HLA-B15 has two public antigens.
    Schwartz BD; Luehrman LK; Lee T; Rodey GE
    Hum Immunol; 1980 Dec; 1(4):331-45. PubMed ID: 6167552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cytotoxic monoclonal antibody specific for the private alloantigenic determinant of the HLA-B 13 molecule.
    Müller C; Herbst H; Löffler G; Ziegler A; Wernet P
    Hum Immunol; 1983 Aug; 7(4):229-37. PubMed ID: 6193088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody (Tü48) defining alloantigenic class I determinants specific for HLA-Bw4 and HLA-Aw23,-Aw24 as well as -Aw32.
    Müller C; Ziegler A; Müller G; Schunter F; Wernet P
    Hum Immunol; 1982 Dec; 5(4):269-81. PubMed ID: 6186654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity.
    Duquesnoy RJ
    Int J Immunogenet; 2012 Feb; 39(1):1-9. PubMed ID: 21981757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A monoclonal antibody (GF 22.1) detecting different patterns of HLA class I cross-reactivities at different dilutions.
    Sensi A; Baricordi OR; Melchiorri L; Balboni A; Pletschette M; Grappa MT; Mattiuz PL
    Tissue Antigens; 1985 Sep; 26(3):204-9. PubMed ID: 3863262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen.
    Gaston JS; Rickinson AB; Epstein MA
    J Exp Med; 1983 Aug; 158(2):280-93. PubMed ID: 6193217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of responder cell activity in mixed leukocyte culture reactions. I. Evidence of cross-reactivity of B7-antibody with HLA-B8.
    de Rooij-Doyer E; Bruning JW; van Rood JJ
    Tissue Antigens; 1981 Sep; 18(3):154-65. PubMed ID: 7336421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
    Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
    J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Polymorphic determinants of HLA-A, B molecules analysed with monoclonal antibodies: serologic characterization and evaluation of technical variations].
    Crepaldi T; Marsico D; Peruccio D; Richiardi P
    Riv Emoter Immunoematol; 1984; 31(1):36-48. PubMed ID: 6085186
    [No Abstract]   [Full Text] [Related]  

  • 33. Serological mapping of HLA-epitopes with monoclonal antibodies and its interpretation by sequenced HLA-molecules.
    Harpprecht J; Olde K; Westphal E; Müller-Ruchholtz W
    Tissue Antigens; 1989 Sep; 34(3):170-8. PubMed ID: 2480657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New aspects of HLA compatibility in organ transplantation].
    Snanoudj R; Legendre C
    Nephrol Ther; 2016 Apr; 12 Suppl 1():S125-30. PubMed ID: 26968475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-reactions of HLA antibodies: VII. Rate of sensitization and serological specificity.
    Kostyu DD; Bernard NF; Amos DB
    Tissue Antigens; 1979 Apr; 13(4):298-306. PubMed ID: 88777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-reactivity between human and murine lymphocyte antigens. IV. Reactivity of H-2 alloantisera with HLA-A, B antigens.
    Quaranta V; Pellegrino MA; Callahan GN; Ferrone S
    Immunogenetics; 1981; 13(4):311-7. PubMed ID: 6168581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New HLA antigenic determinant shared by A2 and a subtype of Bw16 molecules detected by a monoclonal antibody.
    Richiardi P; Crepaldi T; Malavasi F; Carbonara A
    Hum Immunol; 1983 May; 7(1):17-23. PubMed ID: 6189810
    [No Abstract]   [Full Text] [Related]  

  • 38. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens.
    El-Awar N; Lee JH; Tarsitani C; Terasaki PI
    Hum Immunol; 2007 Mar; 68(3):170-80. PubMed ID: 17349872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope Analysis Aids in Transplant Decision Making by Determining the Clinical Relevance of Apparent Pre-Transplant Donor Specific Antibodies (DSA).
    Pandey S; Harville TO
    Ann Clin Lab Sci; 2019 Jan; 49(1):50-56. PubMed ID: 30814077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The antigenic structure of HLA-A2: an analysis with competitive binding assays and monoclonal antibodies.
    Ways JP; Parham P
    J Immunol; 1983 Aug; 131(2):856-63. PubMed ID: 6190942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.